(A) Pulmonary disease most commonly occurs after 5 to 6 months after initiation of treatment.

(B) Symptoms most commonly include chest pain.

(C) Chest X-ray findings most commonly show reticular-nodular infiltrates.

(D) Pulmonary function testing most commonly reveals a decrease in DLCO.